Marshall Wace
COYA icon

Marshall Wace’s Coya Therapeutics COYA Stock Holding History

Marshall Wace’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Buy
249,793
+24,001
+11% +$111K ﹤0.01% 2018
2026
Q1 		$890K Buy
225,792
+434
+0.2% +$2.03K ﹤0.01% 2194
2025
Q4 		$1.31M Buy
225,358
+183,533
+439% +$1.12M ﹤0.01% 1794
2025
Q3 		$238K Buy
+41,825
New +$254K ﹤0.01% 2519

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marshall Wace's COYA Position: Q2 2026 in Review

Marshall Wace increased its Coya Therapeutics (COYA) stake by 11% in Q2 2026, buying an estimated $111K and bringing the position to 249,793 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #2018.

Marshall Wace first reported a position in COYA in Q3 2025 and has held it in 4 quarters since. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • Marshall Wace held 249,793 shares of Coya Therapeutics worth $1.46M as of Q2 2026.
  • Marshall Wace bought 24,001 Coya Therapeutics shares in Q2 2026, an estimated $111K.
  • Coya Therapeutics made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2018 holding.
  • Marshall Wace first reported a position in Coya Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.